DNTH vs ERAS: stock comparison and AI forecast
Dianthus Therapeutics, Inc. /De/ (DNTH) and Erasca, Inc. (ERAS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DNTH Dianthus Therapeutics, Inc. /De/
- Market Cap
- $4.60B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
ERAS Erasca, Inc.
- Market Cap
- $4.91B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DNTH and ERAS have similar market capitalizations ($4.60B and $4.91B).
- ERAS carries 0.20 times debt per unit of equity, against 0.04 times for DNTH.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DNTH | ERAS |
|---|---|---|
| Market Cap | $4.60B | $4.91B |
| P/B Ratio | 3.93x | 13.58x |
| EPS | $-4.22 | $-0.46 |
| Book Value/Share | $20.95 | $1.03 |
| FCF/Share | – | $-0.28 |
Profitability & Margins
| Metric | DNTH | ERAS |
|---|---|---|
| ROE | -16.4% | – |
| ROA | -15.8% | – |
| ROIC | -18.5% | -75.4% |
| Operating Margin | -18828.3% | – |
| Net Margin | -16615.9% | – |
| EBT Margin | -18828.3% | – |
Financial Health
| Metric | DNTH | ERAS |
|---|---|---|
| Current Ratio | 26.10x | 8.29x |
| D/E Ratio | 0.04x | 0.20x |
| Financial Leverage | 1.04x | 1.20x |
| Working Capital | $863M | $245M |
Cash Flow
| Metric | DNTH | ERAS |
|---|---|---|
| Operating Cash Flow | -$155M | -$98M |
| Free Cash Flow | – | -$98M |
| Capital Spending | – | -$60K |
Income Statement
| Metric | DNTH | ERAS |
|---|---|---|
| Operating Income | -$218M | -$303M |
| Net Income | -$192M | – |
| R&D Expense | $176M | $109M |
Dividend & Shareholder Information
| Metric | DNTH | ERAS |
|---|---|---|
| Shares Outstanding | 56M | 350M |
DNTH vs ERAS: stock comparison and AI forecast
Which is bigger, DNTH or ERAS?
DNTH and ERAS have similar market capitalizations ($4.60B and $4.91B).
Which one does Intratio's AI model rank higher, DNTH or ERAS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.